Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$70.53+0.54 (+0.77%)
Close on Nov 18, 2026Market cap $9.47BP/E 18.0Yield –
Globus Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Globus Medical's price to sales ratio was 3.3× on Nov 11, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 2.9× to 8.0×, with a median of 4.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | −1.1 |
| 2025 | Dec 31, 2025 | 4.3× | −0.1 |
| 2024 | Dec 31, 2024 | 4.5× | −0.1 |
| 2023 | Dec 29, 2023 | 4.6× | −3.1 |
| 2022 | Dec 30, 2022 | 7.7× | −0.2 |
| 2021 | Dec 31, 2021 | 7.9× | −0.7 |
| 2020 | Dec 31, 2020 | 8.6× | +1.0 |
| 2019 | Dec 31, 2019 | 7.6× | +1.5 |
| 2018 | Dec 31, 2018 | 6.1× | −0.3 |
| 2017 | Dec 29, 2017 | 6.5× | +2.2 |
| 2016 | Dec 30, 2016 | 4.3× | −0.7 |
| 2015 | Dec 31, 2015 | 5.0× | +0.1 |
| 2014 | Dec 31, 2014 | 4.9× | +0.4 |
| 2013 | Dec 31, 2013 | 4.5× | +1.9 |
| 2012 | Dec 31, 2012 | 2.6× | – |
See a number that looks wrong?